Spotlight On ATTR-CM
Welcome to Spotlight On ATTR-CM, your go-to source for the latest research, diagnostic advancements, and therapeutic strategies in transthyretin amyloid cardiomyopathy (ATTR-CM). Join leading cardiologists and researchers as they share their insights on this intricate condition to enhance patient care and outcomes.
61-75 of 95
Refractory ATTR-CM: Persistent Burden Is Not Always Drug Failure
Spotlight On ATTR-CMRefractory ATTR-CM: Persistent Burden Is Not Always Drug Failure
Acoramidis in Pregnancy: Sparse Human Data in ATTR-CM
Spotlight On ATTR-CMAcoramidis in Pregnancy: Sparse Human Data in ATTR-CM
Acoramidis in ATTR-CM: Targeted Stabilization, Not Reversal
Spotlight On ATTR-CMAcoramidis in ATTR-CM: Targeted Stabilization, Not Reversal
Ongoing Trials in ATTR-CM: What Current Study Design May Clarify
Spotlight On ATTR-CMOngoing Trials in ATTR-CM: What Current Study Design May Clarify
Primary Research in ATTR-CM: What the Current Evidence Actually Shows
Spotlight On ATTR-CMPrimary Research in ATTR-CM: What the Current Evidence Actually Shows
ATTR-CM Guidelines and Regulation: Confirm First, Treat Within Label
Spotlight On ATTR-CMATTR-CM Guidelines and Regulation: Confirm First, Treat Within Label
- advertisement
Head-to-Head Trials in ATTR-CM: Comparative Signal Without Simple Hierarchy
Spotlight On ATTR-CMHead-to-Head Trials in ATTR-CM: Comparative Signal Without Simple Hierarchy
Acoramidis Prescribing Updates in ATTR-CM: What the Label Clarifies
Spotlight On ATTR-CMAcoramidis Prescribing Updates in ATTR-CM: What the Label Clarifies
Acoramidis Sequencing in ATTR-CM: Start With Confirmation
Spotlight On ATTR-CMAcoramidis Sequencing in ATTR-CM: Start With Confirmation
The ATTR-CM Therapeutic Landscape: Mechanisms of Action and Treatment Considerations
Spotlight On ATTR-CMThe ATTR-CM Therapeutic Landscape: Mechanisms of Action and Treatment Considerations
First-Line Therapy in ATTR-CM: Subtype Confirmation and Treatment Continuity
Spotlight On ATTR-CMFirst-Line Therapy in ATTR-CM: Subtype Confirmation and Treatment Continuity
Tafamidis Prescribing Updates in ATTR-CM: Long-Term Therapy Following Appropriate Diagnosis
Spotlight On ATTR-CMTafamidis Prescribing Updates in ATTR-CM: Long-Term Therapy Following Appropriate Diagnosis
- advertisement
Cardiac MRI in ATTR-CM: Role in Tissue Characterization and Diagnostic Workup
Spotlight On ATTR-CMCardiac MRI in ATTR-CM: Role in Tissue Characterization and Diagnostic Workup
Serum Free Light Chains in ATTR-CM: An Exclusion Signal, Not a Diagnosis
Spotlight On ATTR-CMSerum Free Light Chains in ATTR-CM: An Exclusion Signal, Not a Diagnosis
Serum and Urine Immunofixation Electrophoresis in ATTR-CM: Exclusion Before Confirmation
Spotlight On ATTR-CMSerum and Urine Immunofixation Electrophoresis in ATTR-CM: Exclusion Before Confirmation